Last week, Eli Lilly said it would cut the monthly price of its starter dose of Zepbound to $349. The U.S. drugmaker also is ...

Novo Nordisk A/S (NVO) has slashed prices for its blockbuster weight-loss drug Wegovy as competition in the obesity drug market heats up, with ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford the $1, ...

Strong demand for both Wegovy and Eli Lilly’s Zepbound led to shortages of those products. Compounding pharmacies pounced, taking market share with their custom-made, lower-cost versions of GLP ...

Last week, Eli Lilly (LLY) said it would cut the monthly ... the drugs during the shortage will have to wind down production. Wegovy and Zepbound are part of a GLP-1 class of treatments that ...

Novo Nordisk Cuts Wegovy Prices, Following Similar Move by Zepbound-Maker Eli Lilly Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance.